Related Experiment Videos
[Systematic extended lymph node dissection in curative therapy of stomach cancer]
1Chirurgische Klinik mit Poliklinik, Friedrich-Alexander-Universität Erlangen.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|December 1, 1993
Summary
Systematic extended lymph node dissection (SELD) improved survival for gastric carcinoma patients in stages IA, IB, II, and IIIA without increasing surgical risks. Survival rates were similar for advanced stages IIIB and IV.
Area of Science:
- Oncology
- Surgical Oncology
- Gastrointestinal Surgery
Context:
- Gastric carcinoma presents a significant global health challenge.
- Surgical resection is a primary curative treatment for gastric cancer.
- The extent of lymph node dissection is crucial for accurate staging and survival outcomes.
Purpose:
- To prospectively evaluate the impact of systematic extended lymph node dissection (SELD) on survival and complications in surgically treated gastric carcinoma patients.
- To determine if SELD offers survival benefits across different stages of gastric cancer.
Summary:
- A prospective study involving 545 gastric carcinoma patients compared outcomes with and without SELD.
- SELD did not increase surgical mortality or postoperative complications.
- Significant survival improvement was observed in stage II, with a positive trend in stages IA, IB, and IIIA.
- No survival difference was noted for stages IIIB and IV patients regardless of SELD.
Impact:
- SELD is a valuable surgical approach for improving survival in early to moderately advanced gastric carcinoma.
- The findings support the adoption of SELD for specific stages of gastric cancer to enhance patient outcomes.
- This study provides evidence-based guidance for surgical decision-making in gastric cancer treatment.